Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study
We examined whether influenza vaccination affects 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and death among intensive care unit (ICU) survivors aged ≥ 65 years.
Danish Intensive Care Database data on all elderly ( ≥ 65 years) patients hospitalized in Danish ICUs in the period 2005–2015, and subsequently discharged, were linked with data from other medical registries, including data on uptake of the seasonal influenza vaccine. We computed these patients’ 1-year risk of hospitalization for myocardial infarction, stroke, heart failure, or pneumonia, and their 1-year risk of all-cause mortality. Hazard ratios (HRs) with 95% confidence intervals (CIs) were computed using Cox proportional hazards regression, with adjustment and propensity score matching applied to handle confounding.
The study included 89,818 ICU survivors. The influenza vaccinated patients (n = 34,871, 39%) were older, had more chronic diseases, and used more prescription medications than the unvaccinated patients. Adjusted 1-year mortality was decreased among the vaccinated versus the unvaccinated patients (19.3% versus 18.8%; adjusted HR, 0.92; 95% CI 0.89–0.95). Influenza vaccination was also associated with a decreased risk of stroke (adjusted HR, 0.84; 95% CI 0.78–0.92), but only a small, non-significantly decreased risk of myocardial infarction (adjusted HR, 0.93; 95% CI 0.83–1.03). There was no association between vaccination and subsequent hospitalization for heart failure or pneumonia. Propensity score matched analyses confirmed these findings.
Compared with the unvaccinated ICU survivors, the influenza vaccinated ICU survivors had a lower 1-year risk of stroke and a lower 1-year risk of death, whereas no substantial association was observed for the risk of hospitalization for myocardial infarction, heart failure, or pneumonia. Our findings support influenza vaccination of individuals aged ≥ 65 years.
KeywordsCardiovascular diseases Cohort studies Infection Influenza vaccines Intensive care Mortality
CFC, RWT, MS, and HTS conceived the study idea and designed the study. CFC and HTS obtained the funding. CFC and LP collected the data and carried out the analyses. CFC organized the writing and wrote the first draft. All authors participated in the discussion and interpretation of the results. All authors critically revised the manuscript for intellectual content and approved the final version before submission. CFC is the guarantor.
This research received financial support from the Danish Medical Research Council (Grant 271-05-0511), from the Aarhus University Research Foundation, and from the Program for Clinical Research Infrastructure (PROCRIN) established by the Lundbeck Foundation and the Novo Nordisk Foundation and administered by the Danish Regions. The funding agencies had no role in the design, conduct, analysis, or reporting of this study.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
- 3.Baldwin MR (2015) Measuring and predicting long-term outcomes in older survivors of critical illness. Minerva Anestesiol 81:650–661Google Scholar
- 8.Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM (2015) Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA 314:1488–1497. https://doi.org/10.1001/jama.2015.12160 CrossRefGoogle Scholar
- 11.Warren-Gash C, Hayward AC, Hemingway H, Denaxas S, Thomas SL, Timmis AD, Whitaker H, Smeeth L (2012) Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis 206:1652–1659. https://doi.org/10.1093/infdis/jis597 CrossRefGoogle Scholar
- 13.Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA (2008) Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 372:398–405. https://doi.org/10.1016/s0140-6736(08)61160-5 CrossRefGoogle Scholar
- 14.Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353. https://doi.org/10.1056/nejmoa1702090 CrossRefGoogle Scholar
- 15.Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C (2018) How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine 36:442–452. https://doi.org/10.1016/j.vaccine.2017.12.019 CrossRefGoogle Scholar
- 16.Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, Cannon CP (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720. https://doi.org/10.1001/jama.2013.279206 CrossRefGoogle Scholar
- 20.Demirdogen Cetinoglu E, Uzaslan E, Sayiner A, Cilli A, Kilinc O, Sakar Coskun A, Hazar A, Kokturk N, Filiz A, Polatli M, Group TS (2017) Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Hum Vaccin Immunother 13:2072–2077. https://doi.org/10.1080/21645515.2017.1339851 CrossRefGoogle Scholar
- 22.Demicheli V, Jefferson T, Di Pietrantonj C, Ferroni E, Thorning S, Thomas RE, Rivetti A (2018) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2(5):5–9Google Scholar
- 29.Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 11:83. https://doi.org/10.1186/1471-2288-11-83 CrossRefGoogle Scholar
- 32.Sturmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S (2006) A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 59:437–447. https://doi.org/10.1016/j.jclinepi.2005.07.004 CrossRefGoogle Scholar
- 35.Nichols MK, Andrew MK, Ye L, Hatchette TF, Ambrose A, Boivin G, Bowie W, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA, Serious Outcomes Surveillance Network of the Canadian Immunization Research N (2018) The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada. Clin Infect Dis. https://doi.org/10.1093/cid/ciy1009 Google Scholar
- 38.Hellfritzsch M, Thomsen RW, Baggesen LM, Larsen FB, Sorensen HT, Christiansen CF (2017) Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system. Vaccine 35:2396–2403. https://doi.org/10.1016/j.vaccine.2017.03.040 CrossRefGoogle Scholar
- 41.Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ, Group CT (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 377:1119–1131. https://doi.org/10.1056/nejmoa1707914 CrossRefGoogle Scholar